Managing post-bariatric hypoglycemia: a systematic review of pharmacological therapies
Abstract
Background: Post-bariatric hypoglycemia (PBH) is a challenging and increasingly recognized complication following bariatric surgery, particularly Roux-en-Y gastric bypass (RYGB). Multiple pharmacologic interventions have been explored for managing PBH, but evidence is scattered. This study aimed to systematically synthesize the evidence from comparative studies, single-intervention trials, case reports, and registered clinical trials to evaluate the efficacy of drug therapies for PBH.
Methods: This systematic review and mixed treatment comparison meta-analysis was conducted in accordance with PRISMA guidelines and registered on Open Science Framework. Databases searched included MEDLINE, Cochrane CENTRAL, and Google Scholar, with no language or year restrictions. Eligible studies included randomized clinical trials (RCTs), observational studies, single-drug evaluations, and case reports addressing pharmacologic treatments for PBH. Risk of bias was assessed using Cochrane and Joanna Briggs Institute tools. Mixed treatment comparisons were conducted with relative risk (RR) as effect estimates, and evidence quality was assessed with the GRADE approach.
Results: Out of 2134 records screened, 13 comparative studies, five single-intervention studies, and 15 case reports were included. Among comparative studies, 12 were RCTs and one was a retrospective study. Meta-analysis revealed that anakinra and empagliflozin significantly reduced the risk of hypoglycemia compared to placebo…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38
- Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens
- Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury
- The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model
- Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer
- In vivo tracking of bioorthogonally labeled T-cells for predicting therapeutic efficacy of adoptive T-cell therapy
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.